The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Modern medicines series SGLT2 Inhibitors: Webinar 3 - SGLT2 inhibitors and the kidney

Modern medicines series SGLT2 Inhibitors: Webinar 3 - SGLT2 inhibitors and the kidney

Publication date: Wednesday, 10 March 2021
Contributor(s): Cliff Bailey, Pam Brown

Professor Cliff Bailey and Dr Pam Brown discuss the reno-protective effects of SGLT2 inhibitors and their role in the management diabetic kidney disease, specifically: Kidney disease in type 2 diabetes; SGLT2 inhibitors and glomerular filtration rate; SGLT2 inhibitors reduced albuminuria; Slow decline in glomerular filtration rate; Reduce albuminuria; Delay progression of CKD without diabetes; Value in prevention and treatment of diabetic kidney disease.

Download the factsheet to this webinar below or watch the on-demand video here:
View the on-demand webinar

And don't forget to complete the CPD programme on our Sister site BJPCN to get your CPD points and download your certificate: 
Go to the CPD programme*

This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant.


*Please note that registration is required to complete the CPD module. Simply register to create your free-of-charge personal account
 

Sponsorship information:
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant
Topics covered:
Category: Webinars
Edition: Volume 1 Number 3 February-March 2021
Contributor(s): Cliff Bailey, Pam Brown

Article search and filter